Shares of Tango Therapeutics, Inc. (TNGX) have gained 18.7% over the past four weeks to close the last trading session at $6.46, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$10.43 indicates a potential upside of 61.5%.The mean estimate comprises seven short-term price targets with a standard deviation of $2.23. While the lowest estimate of$8.00 indicates a 23.8% increase fr ...